Takara Bio Europe announced today a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.

Cherwell Laboratories has confirmed its continued support for the Pharmaceutical & Healthcare Sciences Society (PHSS) Annual Conference 2022.

Bio-Rad Laboratories, Inc. has introduced a range of type 1 antibodies that inhibit the binding of evolocumab to its target, human proprotein convertase subtilisin/kexin type 9, a protein that has been shown to play a key role in the regulation of cholesterol levels.

Bio-Rad Laboratories, Inc. has extended its range of StarBright Dyes to provide greater flexibility in multicolor flow cytometry panels.

Lonza has launched the Nebula® Multimode Reader, the first multimode reader qualified for use with Lonza’s turbidimetric, chromogenic and recombinant endotoxin detection methods.

Jackson ImmunoResearch announces a new addition to its range of products for scientists developing immunoassays for the serology and diagnostics markets.

Biosynth Carbosynth announces today that it has signed an agreement to acquire EUCODIS Bioscience.

Carterra, Inc. and La Jolla Institute for Immunology (LJI) announced today that LJI has acquired a Carterra LSA instrument to enhance its antibody screening and characterization work.

ERS Genomics Limited is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD.

Quest Diagnostics has announced the nationwide availability of the company's lab-developed molecular diagnostic test to aid in the diagnosis of infection with the monkeypox virus, with plans to launch the CDC's orthopoxvirus test in the first half of August.